Stocks
Denali Therapeutics (DNLI) ROA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | -35.7% | 4.43% | -20.7% | -22.3% | -12.6% | -8.68% | ||
| Changes by years, y/y, % | -30pp | +40pp | -25pp | -2pp | +10pp | +18.1% | |||
Denali Therapeutics. ROA, %
Denali Therapeutics. ROA, changes, pp
Denali Therapeutics (DNLI) ROA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| ROA, % | ? | -26.3% | -9.83% | -10.1% | -12.6% | -8.68% | -8.68% | |
| Changes by years, y/y, % | -5pp | +12pp | +14pp | +10pp | +18pp | |||
| Changes by quarters, q/q, % | -4pp | +16pp | 0pp | -3pp | +4pp | |||
